Fighting poor quality health products in times of Covid-19 and beyond: the need for a multi-stakeholder approach

World Health Organization (WHO) estimates from 2017 indicates that 10.5% of medical products available in low- and middle-income countries (LMICs) are “substandard or falsified” (SF). Substandard health products are approved by the national regulators, but they do not comply with adequate standards due to undetected errors, negligence, or poor practice in manufacturing, transportation, or storage. ...

Collaboration of Quamed with Mauritanian Health Ministry

Jean-Christophe Pelissier meets with Minister of Health Minister Hon. Dr. Mohamed Nedhirou Hamed in the light of our collaboration to introduce good pharmaceutical practices in Mauritania. This will be done through: Phase 1: An inventory of private and public wholesalers based on the WHO MQAS and BPDS guidelines Phase 2: A proposal for specifications that ...

WHO on new guidance to promote Strong, Efficient and Sustainable Regulatory Systems

29 April 2021 Departmental news Reading time: 2 min (546 words) The World Health Organization, (WHO) has recently published two documents that will be critical for countries’ regulatory system strengthening activities, including regulatory cooperation, convergence and transparency. Good Regulatory Practices (GRP) and Good Reliance Practices (GReP), published as Annexes 10 and 11 in the 55th report of the WHO Expert ...

Fighting poor-quality health products in times of COVID19 and beyond

Dear Colleagues and Friends, To prevent, detect and combat poor-quality health products, it is urgent to strengthen the collaboration and synergies between the different stakeholders, and in particular regulators and law enforcement authorities. I am happy to inform you that Belgium organizes, in the frame of the 30th session of the Commission on Crime Prevention and Criminal Justice (CCPCJ), with the support of UNODC, ...

Rafaella’s Literature Update

Be-cause Health & QUAMED literature updates ·         Ref. Bourasseau, A., Lavergne, L. & Ravinetto, R. Assessments of the quality systems of pharmaceutical distributors: a remote approach to be applied in times of COVID-19 and beyond. J of Pharm Policy and Pract 2021; 14, 43 Dear Friend, Today, I would like to present a very recent publication, which just appeared in ...

Covid-19 vaccines patents interview

QUAMED member and ITM expert Raffaella Ravinetto was invited by TerZake, a Belgium/Flemish television news programme to talk about Covid-19 vaccines patents. “Some countries produce medicines. With adequate investment, they could also produce corona vaccines. Not for their own country – we don’t want vaccine nationalism – but for the region.” To see her interview, please ...

Enabel Round Table

#TeamEuropeQUAMED was honoured to participate in a high-level round table hosted by Enabel, and in presence of Minister Kitir on May 6. Participants spanning the Belgian life sciences, academic research and development-cooperation ecosystem contemplated potential contributions and added value that Belgium can bring to scaling up the production capacity of vaccines, medicines and medical products ...

Job Alert: Global Fund

VACANCY: Global Fund is hiring for the following positions. Apply if interested or share with friends! Specialist, Vector Control Quality Assurance – GL D https://theglobalfund.wd1.myworkdayjobs.com/en-US/External/job/Geneva/Vector-Control-Quality-Assurance-Specialist—GL-D_JR1590 Specialist, Medical Device and Personal Protective Equipment Quality Assurance – GL D – Temporary until May 2022 https://theglobalfund.wd1.myworkdayjobs.com/en-US/External/job/Geneva/Specialist–Medical-Device-and-Personal-Protective-Equipment-Quality-Assurance—GL-D—Temporary-until-May-2022_JR1591 Specialist, Pharmaceuticals Products Quality Assurance, Supply Operations – GL D https://theglobalfund.wd1.myworkdayjobs.com/en-US/External/job/Geneva/Specialist–Pharmaceuticals-Products-Quality-Assurance–Supply-Operations—GL-D_JR1526

RAFAELLA’S LITERATURE UPDATE

Be-cause Health & QUAMED literature updates Ref. Yaneth Gil-Rojas et al. Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia. Rev Bras Ginecol Obstet 2018; 40(05): 242-250 DOI: 10.1055/s-0038-1655747 Dear Friend, In the 21st edition of the WHO Model List of Essential Medicines issued in ...